SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Momentum- Dr. Jekyll/Mr. Hyde
An SI Board Since December 1999
Posts SubjectMarks Bans
55 11 0
Emcee:  RWReeves Type:  Unmoderated
Biotech has always had this interesting dual personality; research vs. products, burn vs. earnings, stereotypical white lab coat set and the management types; MD/PhD vs. MBA. Jekyll vs. Hyde? The distinction isn't always clear.

And then there's value vs. momentum.

Many of the biggest moves in biotech have been on momentum; that is, the gains are based on perception and the investing public falling in love or hate with an issue more than value. We've seen this many times. Such plays can be very high return but may also carry inordinate risk.

There is a lot of very, very good discussion on SI regarding biotech value. But while discussions of momentum, day trading, shorts and volatility plays including derivatives come up they are often lost in the general discussion. Often these posts are very interesting and sometimes very incisive.

I'd like to add a forum for discussions of this type; momentum plays in pharma, biotech and medical devices. In addition, I would encourage the interface of value investors and momentum types (assuming these are not the same bunch). We have an arguably volatile and some would say speculative market-the highest returns are likely to be in companies that have excellent value and are just attracting attention with their stories and hence momentum. Others have the momentum but it may be mostly hype. We already know about value as it is well discussed elsewhere on SI.

Please feel free to jump in with ideas, recommendations, discussions and passionate (but please-informed)rants. Discussions of TA and trading tools as they apply to this market segement are welcome.

CAVEAT: Momentum plays are highly speculative. While attractive to many investors, YOU MUST do your own Due Diligence before you invest in anything, even when it's hot. If you trade momentum, you know the rules and you are aware of the high risk.

Intelligent discussions of long or short positions are welcome but if you come in touting a particular POV and have no real underlying knowledge of the issues you probably will find yourself up against people who DO know the issues and could look pretty silly. So discussion please-but avoid touting or short ravings.

I hope you will find the discussions to be of value.

RWR
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
55Rick, <i> However, I'm a trader</i> Acknowledgement is the keybiowa-7/25/2000
54Good sign, imo. However, I'm a trader (in addition to holding a long-term bscaram(o)uche-7/25/2000
53Tim Quast of Informedinvestors.com writes me that attendance at its biotech foruJMarcus-7/25/2000
52 An interesting perspective: Message 13430452 Momo -OUT Value-IN RWRRWReeves-4/17/2000
51 JUST FOR FUN-Tired of red in the quote fields? It could be worse (or better) RWReeves-3/9/2000
50 Biochips Message 13001891 kind of an interesting article. I wonder if there aRWReeves-3/4/2000
49 You are right, and "relatively" is the operative term. Many Canadian RWReeves-2/25/2000
48 May as well park this here. NERX, which has (still is) had a nice run, also haRWReeves-2/25/2000
47 RWR, concerning GENXY i think its relativly undervalued most likely its becaudalroi-2/25/2000
46 TNN, That's a shame. MZ's famous REGN is stealing the show today. I wouRWReeves-2/23/2000
45 Incidentally, GLIA has more momentum than any of my other holdings this morningTorben Noerup Nielsen-2/23/2000
44 RWR, at least we have something in common: GLIA and ELN!Torben Noerup Nielsen-2/23/2000
43 Dr. Jekylls: some biotechs with value but no momo: My favorite: GLIA and a niRWReeves-2/23/2000
42 Trading halted all day in TXB pending news. Message 12910184 Haven't founRWReeves-2/20/2000
41 Rick: Just took a look at their profile. It's medical imaging, nope neverscaram(o)uche-2/18/2000
40 Richard--you mentioned that maybe we should look to equip. and Instr.----a frieRick Buskey-2/18/2000
39 agreed, and it will perhaps "matter" in a couple of weeks. (eom) scaram(o)uche-2/18/2000
38 Rick, Had already noted. Closer look means trying to figure out if this drug biowa-2/18/2000
37 Take a closer look? Note why they are break-even rather than profitable...... scaram(o)uche-2/18/2000
36 Rick, One glance at SQNM would suggest that it has already trickled down. NBSbiowa-2/18/2000
35 Momentum..... is instrumentation and equipment coming next? Genomics tricklescaram(o)uche-2/18/2000
34 RWR, <i>GT stalled for the moment</i> Not sure I'd call TGEN biowa-2/18/2000
33 With a day like this it's hard to tell which sectors are hot. I wish they wRWReeves-2/18/2000
32 Biowa: Haven't a clue. Rick.neuro scaram(o)uche-2/17/2000
31 Rick, Gene therapy still running, neuro or onco up next? biowabiowa-2/17/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):